| Primary |
| Product Used For Unknown Indication |
52.6% |
| Anaesthesia |
5.6% |
| Urinary Tract Infection |
4.6% |
| Pneumonia |
4.1% |
| Pneumonia Aspiration |
4.1% |
| Pneumonia Pneumococcal |
4.1% |
| Hypertension |
3.6% |
| Lower Respiratory Tract Infection |
3.6% |
| Prophylaxis |
2.6% |
| Endotracheal Intubation |
2.0% |
| Pseudomonas Infection |
2.0% |
| Antibiotic Prophylaxis |
1.5% |
| Appendicectomy |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Otitis Externa |
1.5% |
| Abscess |
1.0% |
| Caesarean Section |
1.0% |
| Clostridium Difficile Infection |
1.0% |
| Constipation |
1.0% |
| Helicobacter Infection |
1.0% |
|
| Vomiting |
14.3% |
| Jaundice Cholestatic |
7.1% |
| Malaise |
7.1% |
| Anaphylactic Reaction |
5.4% |
| Jaundice |
5.4% |
| Nausea |
5.4% |
| Renal Impairment |
5.4% |
| Respiratory Arrest |
5.4% |
| Tachycardia |
5.4% |
| Cardiac Arrest |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Mouth Ulceration |
3.6% |
| Oedema |
3.6% |
| Pulmonary Haemorrhage |
3.6% |
| Rash |
3.6% |
| Sepsis |
3.6% |
| Stridor |
3.6% |
| Swollen Tongue |
3.6% |
| Vertigo |
3.6% |
| White Blood Cell Count Increased |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
31.7% |
| Sinus Disorder |
10.6% |
| Pneumonia |
9.3% |
| Pneumonia Aspiration |
9.0% |
| Nosocomial Infection |
6.9% |
| Pneumonia Pneumococcal |
6.9% |
| Lower Respiratory Tract Infection |
5.8% |
| Pseudomonas Infection |
4.2% |
| Respiratory Failure |
3.4% |
| Staphylococcal Infection |
2.1% |
| Moraxella Infection |
1.6% |
| Urinary Tract Infection |
1.3% |
| Drug Use For Unknown Indication |
1.1% |
| Meningitis |
1.1% |
| Sepsis |
1.1% |
| Antibiotic Prophylaxis |
0.8% |
| Empyema |
0.8% |
| Endotracheal Intubation |
0.8% |
| Postoperative Analgesia |
0.8% |
| Streptococcal Sepsis |
0.8% |
|
| Vomiting |
23.3% |
| Respiratory Arrest |
18.3% |
| White Blood Cell Count Increased |
8.3% |
| Jaundice Cholestatic |
6.7% |
| Clostridium Difficile Infection |
5.0% |
| International Normalised Ratio Increased |
5.0% |
| Wheezing |
5.0% |
| Clostridium Test Positive |
3.3% |
| Diarrhoea |
3.3% |
| Pseudomonas Infection |
3.3% |
| Vision Blurred |
3.3% |
| Clostridial Infection |
1.7% |
| Colitis |
1.7% |
| Gastroenteritis Norovirus |
1.7% |
| Pain |
1.7% |
| Pruritus Generalised |
1.7% |
| Rash Generalised |
1.7% |
| Selenium Deficiency |
1.7% |
| Sepsis |
1.7% |
| Status Epilepticus |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.1% |
| Prophylaxis Of Nausea And Vomiting |
15.3% |
| Infection |
4.8% |
| Pain |
4.6% |
| Drug Use For Unknown Indication |
4.1% |
| Nausea |
4.0% |
| Analgesic Therapy |
3.3% |
| Mucosal Inflammation |
3.3% |
| Chemotherapy |
2.8% |
| Hypertension |
2.6% |
| Asthma |
2.3% |
| Atrial Fibrillation |
2.3% |
| Depression |
2.1% |
| Prophylaxis |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Constipation |
2.0% |
| Anxiety |
1.7% |
| B-cell Lymphoma |
1.7% |
| Anaemia |
1.3% |
| Antiemetic Supportive Care |
1.3% |
|
| Vena Cava Thrombosis |
9.9% |
| Dyskinesia |
8.5% |
| Toxicity To Various Agents |
8.5% |
| Vomiting |
8.5% |
| Rectal Haemorrhage |
7.0% |
| Weight Decreased |
7.0% |
| Thrombocytopenia |
5.6% |
| Headache |
4.2% |
| Neutropenia |
4.2% |
| Pneumonia |
4.2% |
| Throat Tightness |
4.2% |
| Upper Gastrointestinal Haemorrhage |
4.2% |
| Urticaria |
4.2% |
| Mood Altered |
2.8% |
| Pyrexia |
2.8% |
| Sepsis |
2.8% |
| Squamous Cell Carcinoma |
2.8% |
| Ventricular Hypertrophy |
2.8% |
| Visual Impairment |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
|
| Interacting |
| Deep Vein Thrombosis |
25.0% |
| Hypertension |
25.0% |
| Infection |
25.0% |
| Otitis Media Acute |
25.0% |
|
| Nausea |
50.0% |
| Vasculitis |
50.0% |
|
